Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | 3003044 | PO / MO |
The patient started the vaccination series but did not complete it; The patient started vaccination series with Vivotif vaccine left by mistake in car for estimated three days; The patient started vaccination series with Vivotif vaccine left by mistake in car for estimated three days; Case reference number US-BN-2024-002257 is a spontaneous case initially received from other health professional via agency (reference number: USBAV24-1768) on 24-Jul-2024 and concerns a patient of unknown demographics. The patient's medical history and concomitant medications were not provided. On unspecified date, the patient left Vivotif vaccine in the car by mistake, estimated for three days (explicitly coded as 'product storage error'). On unspecified dates, the patient started the vaccination series and took unknown number of doses of Vivotif (batch number: 3003044), at an unknown dose, orally, for an unknown indication. As reported, the patient did not complete the vaccination series (explicitly coded as 'product administration error' and 'incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240724-03cd4f to US-BAVARIAN NORDIC A/S-US-BN-2024-002257, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A patient of unknown demographics left Vivotif vaccine in the car by mistake, estimated for three days, which is considered as product storage error. Reportedly, the patient started the vaccination series and took unknown number of doses of Vivotif for an unknown indication. As reported, the patient did not complete the vaccination series, which is considered as product administration error and incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to Vivotif. Incomplete course of vaccination, product administration error and product storage error are considered as listed per company convention. The patient's medical history and concomitant medication were not provided. Incomplete course of vaccination, product administration error and product storage error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown demographics left Vivotif vaccine in the car by mistake, estimated for three days, which is considered as product storage error. Reportedly, the patient started the vaccination series and took unknown number of doses of Vivotif for an unknown indication. As reported, the patient did not complete the vaccination series, which is considered as product administration error and incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to Vivotif. Incomplete course of vaccination, product administration error and product storage error are considered as listed per company convention. The patient's medical history and concomitant medication were not provided. Incomplete course of vaccination, product administration error and product storage error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None